Trans-Atlantic Trade: What the TTIP Negotiations Mean for the Pharmaceutical and Biotech Industries (info and registration here).
Agenda
1:00 – 1:30: Registration
1:30 – 2:00: Welcome and Keynote
Robert Coughlin, President & CEO, MassBio
Susie Kitchens, Consul-General, British Consulate-General Boston
2:00 – 3:30: Regulatory Frameworks: TTIP and the Implications for BioPharma- A Government Perspective
Dara Corrigan, ‎Assistant Commissioner for Global Regulatory Policy at FDA
Thea Emmerling, Minister Counsellor, Head of Health, Food Safety and Consumer Affairs Section, European Union Delegation to the United States of America
Sabine Haubenreisser, European Medicines Agency Liaison Official at the US FDA
3:30 – 3:45: Coffee Break
3:45 – 5:15: Transatlantic BioPharma Regulation: A Business Perspective on TTIP Deliverables
Edward Garmey, Consultant at Alacrita
David Talbot, Director, International Government Affairs at Eli Lilly
Sheikh Usman Iqbal, Senior Medical Affairs Leader, Global Medical Affairs, AstraZeneca
Moderated by: Ken Levinson, Executive Director, Washington International Trade Association (WITA)
5:15 – 7:00: Reception and Networking